Clovis Oncology, Inc. (CLVSQ) vs Cerenome, Inc. (CNSY)
Clovis Oncology, Inc. and Cerenome, Inc. are both Biotechnology companies. Clovis Oncology, Inc. and Cerenome, Inc. are of similar size ($14.3M and $14.2M). Clovis Oncology, Inc. grew revenue faster over the last twelve months: −14.8% against −21.0%. Clovis Oncology, Inc. has the higher net margin (−189.4% vs −526.5%) and the higher return on invested capital (0.00% vs −532.8%). Across the 17 metrics below, Clovis Oncology, Inc. leads on 11 and Cerenome, Inc. on 6.
Valuation
Profitability
| Metric | CLVSQ | CNSY | Biotechnology median |
|---|---|---|---|
| Gross margin | 72.21% | 100.00% | 65.16% |
| Operating margin | (155.38%) | (628.12%) | 0.00% |
| Net margin | (189.37%) | (526.48%) | 0.00% |
| Free cash flow margin | (132.19%) | (560.29%) | 0.00% |
| Return on equity | 78.31% | (520.84%) | (57.72%) |
| Return on assets | (58.94%) | (181.53%) | (49.22%) |
| Return on invested capital | 0.00% | (532.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack